Colon cancer stands as one of the most prevalent malignancies worldwide. The World Health Organization (WHO) classifies it as the third most frequently diagnosed cancer globally, accounting for nearly ten percent of all oncological cases. While recent years have witnessed significant advancements in therapeutic options and improved survival rates, largely attributed to increased early diagnostic screenings, there’s also a concerning trend of rising incidence among individuals under 50 years of age. Colon cancer typically progresses through five distinct stages, underscoring the vital importance of timely diagnosis. As the disease advances to later stages, treatment options generally become more complex, and the overall prognosis and survival prospects tend to diminish.








